Clopidogrel Dosing: Current Successes and Emerging Factors for Further Consideration-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clopidogrel Dosing: Current Successes and Emerging Factors for Further Consideration

Published:2020-10-26 Issue:5 Volume:109 Page:1203-1211
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Chetty Manoranjenni¹,Ravenstijn Paulien²,Manchandani Pooja³

Affiliation:

1. Discipline of Pharmaceutical Sciences College of Health Sciences University of KwaZulu Natal Durban South Africa

2. qPharmetra LLC Nijmegen The Netherlands

3. Clinical Pharmacology and Exploratory Development Astellas Pharma US Inc. Northbrook Illinois USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2055

Reference25 articles.

1. The role of clopidogrel in 2020: a reappraisal;Patti G.;Cardiovasc. Ther.,2020

2. Plavix®prescribing information. Accessed June 14 2020.

3. Identification of the Human Cytochrome P450 Enzymes Involved in the Two Oxidative Steps in the Bioactivation of Clopidogrel to Its Pharmacologically Active Metabolite

4. The Effect of CYP2C19 Polymorphism on the Pharmacokinetics and Pharmacodynamics of Clopidogrel: A Possible Mechanism for Clopidogrel Resistance

5. Clinical Outcomes and Sustainability of Using CYP2C19 Genotype–Guided Antiplatelet Therapy After Percutaneous Coronary Intervention

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of smoking on the antiplatelet response to clopidogrel: Unravelling the smoker’s paradox;Pathology - Research and Practice;2024-05

2. Ocular toxicity associated with anti‐HER2 agents in breast cancer: A pharmacovigilance analysis using the FAERS database;International Journal of Cancer;2024-01-12

3. CYP2C19 Loss‐of‐Function Variants Associated With Long‐Term Ischemic Stroke Events During Clopidogrel Treatment in the Chinese Population;Clinical Pharmacology & Therapeutics;2023-09-05

4. CYP2C19 Polymorphism in Ischemic Heart Disease Patients Taking Clopidogrel After Percutaneous Coronary Intervention in Egypt;Journal of Epidemiology and Global Health;2023-05-18

5. Assessment of the inhibition risk of chlorophenol substances on cytochrome P450 via cocktail inhibition assays;Toxicology and Applied Pharmacology;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3